Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sao Tome and Principe Tech.
Press releases published on July 4, 2025
Cherry Servers CEO Identifies Five Warning Signs of Excessive Cloud Spend Amid Growing Industry Shift
GlobeNewswire
·
July 4, 2025
Vilnius, Lithuania, July 04, 2025 (GLOBE NEWSWIRE) -- As more businesses evaluate the long-term financial impact of cloud adoption, Vaidas Rutkauskas, the CEO of cloud infrastructure provider Cherry Servers, is raising awareness around five key indicators …
Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions
GlobeNewswire
·
July 4, 2025
Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy Solutions Distinguished experts Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence Steinman have joined Immuthera’s Scientific Advisory …
CertiK 行政總裁在香港交流策略後鞏固機構市場地位
GlobeNewswire
·
July 4, 2025
香港, July 04, 2025 (GLOBE NEWSWIRE) -- 規模最大的 Web3安全服務供應商 CertiK 正式推出CertiK Institutional，這套全週期諮詢與安全解決方案專為全球監管機構、金融機構、銀行、資產管理公司、企業及數碼資產平台打造，進一步強化了該公司在機構領域的市場根基。 是次宣佈為公司聯合創辦人暨行政總裁 Ronghui Gu 教授在香港主持的兩日高級會議及圓桌論壇完美作結。 這些交流合作進一步強化了 CertiK 與受監管金融業及主管機關的合作關係。 …
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
GlobeNewswire
·
July 4, 2025
Tokyo, Japan and Cambridge, UK, 4 July 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it will receive US$4.8 million in milestone payments from Centessa Pharmaceuticals pursuant to its research collaboration with …
AB Science : Le masitinib reçoit l'autorisation de la FDA et de l'EMA pour l’etude confirmatoire de phase 3 dans le cancer de la prostate métastatique hormono-resistant
GlobeNewswire
·
July 4, 2025
COMMUNIQUÉ DE PRESSE LE MASITINIB REÇOIT L'AUTORISATION DE LA FDA ET DE L'EMA POUR L’ETUDE CONFIRMATOIRE DE PHASE 3 DANS LE CANCER DE LA PROSTATE MÉTASTATIQUE HORMONO-RESISTANT, AVEC UNE SÉLECTION DES PATIENTS BASÉE SUR DES BIOMARQUEURS CIBLANT LA …
AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer
GlobeNewswire
·
July 4, 2025
PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN PATIENT SELECTION TARGETING POPULATION MOST LIKELY TO BENEFIT Paris, July 4, 2025, 8am CET AB …
Strüngmann Award zeichnet Gründerteam von Araris Biotech als Preisträger 2025 aus
GlobeNewswire
·
July 4, 2025
Die Expertenjury wählte Dr. Dragan Grabulovski, Dr. Philipp Spycher und Dr. Isabella Attinger-Toller von Araris Biotech, aus einer Gruppe herausragender Life-Science-Unternehmer aus Das Gründerteam von Araris Biotech entwickelt eine bahnbrechende …
Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner
GlobeNewswire
·
July 4, 2025
The expert jury selected Dragan Grabulovski, Ph.D., Philipp Spycher, Ph.D., and Isabella Attinger-Toller, Ph.D. of Araris Biotech, from a group of outstanding life science entrepreneurs The founding team is developing a breakthrough technology to establish …
Aduro Clean Technologies gibt Gewährung von Aktienoptionen und RSUs bekannt
GlobeNewswire
·
July 4, 2025
LONDON, Ontario, July 04, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. („Aduro” oder das „Unternehmen”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), ein Unternehmen im Bereich sauberer Technologien, das die Kraft der Chemie nutzt, um minderwertige …
Aduro Clean Technologies annonce l’octroi d’options sur actions et d’unités d’actions restreintes
GlobeNewswire
·
July 4, 2025
LONDON, Ontario, 04 juill. 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (« Aduro » ou la « Société ») (Nasdaq : ADUR) (CSE : ACT) (FSE : 9D5), une société technologique propre qui recycle chimiquement les matières premières de faible valeur comme …
BTC Miner Users Tap to Earn as Bitcoin Surges to $110K — Investors Make Gains from the Couch
GlobeNewswire
·
July 4, 2025
San Francisco, CA, July 03, 2025 (GLOBE NEWSWIRE) -- Bitcoin has once again asserted its dominance in the digital asset space, recently breaking through the $110,149.8 mark and signaling renewed investor confidence in its long-term value. As Ethereum (ETH …
Starlight Retail Joins Google Cloud Partner Advantage Program to Deliver Advanced Cloud and AI Solutions in Pakistan
GlobeNewswire
·
July 4, 2025
LAHORE, Pakistan, July 03, 2025 (GLOBE NEWSWIRE) -- Starlight Retail, a global technology solutions provider, announced today that it has joined the Google Cloud Partner Advantage program as a Partner level partner for the Service engagement model. This …
Why High-Net-Worth Investors Are Turning to BTC Miner for Daily Crypto Returns Amid Market Turbulence
GlobeNewswire
·
July 4, 2025
Chicago, Illinois, July 03, 2025 (GLOBE NEWSWIRE) -- Introducing BTC Miner — the cloud mining solution designed not for traders, but for wealth builders. For family offices, crypto funds, and large-scale investors seeking dependable yield in a volatile …